The revised version of the implemented in 2025 will elevate the regulatory level for imported medical devices to Category III management.Medical EquipmentProduct registration, quality traceability, and clinical validationThree new compliance elements that agency import agreements must simultaneously cover as legal documents. According to General Administration of Customs data, 63% of medical device import return cases in 2024 involved customs clearance obstacles caused by incomplete agreement terms.Hidden risk points in core agreement clauses
Professionalforeign tradeMarket access licensing clauses
Under the 2025 revised INCOTERMS® rules, it is recommended to adoptCIP termswith special agreements:
A case study of CT equipment imported by a top-tier hospital showed that due to unspecifiedelectromagnetic compatibility testing standardsin the agreement, the equipment caused interference with other hospital devices after installation. The issue was ultimately resolved through a supplementary agreement stipulating:
three core competency matrices that quality foreign trade agents should possess:
© 2025. All Rights Reserved.Shanghai ICP No. 2023007705-2PSB Record: Shanghai No.31011502009912